Cita APA (7a ed.)

YS, J., CW, C., CA, L., HP, Y., HY, L., MY, L., . . . PS, L. (2017). Hyaluronic acid–nimesulide conjugates as anticancer drugs against CD44-overexpressing HT-29 colorectal cancer in vitro and in vivo. Dove Medical Press.

Cita Chicago Style (17a ed.)

YS, Jian, Chen CW, Lin CA, Yu HP, Lin HY, Liao MY, Wu SH, Lin YF, y Lai PS. Hyaluronic Acid–nimesulide Conjugates as Anticancer Drugs Against CD44-overexpressing HT-29 Colorectal Cancer in Vitro and in Vivo. Dove Medical Press, 2017.

Cita MLA (8a ed.)

YS, Jian, et al. Hyaluronic Acid–nimesulide Conjugates as Anticancer Drugs Against CD44-overexpressing HT-29 Colorectal Cancer in Vitro and in Vivo. Dove Medical Press, 2017.